6505-01-168-0537 ( NDC00054-3527-63 , NDC60432-0616-16 , CIBALITH-S SYRUP , NDC00083-6565-76 , NDC00832-8616-16 )

NSN Information
NSN FSC NIIN Item Name INC
6505-01-168-0537 6505 011680537 LITHIUM CITRATE SYRUP,USP 3682
NSN Features
MRC Parameter Characteristics
AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 8.000 MILLIEQUIVALENTS LITHIUM ION PER 5 MILLILITERS
CQCT PRIMARY CONTAINER TYPE BOTTLE
FEAT SPECIAL FEATURES EQUIVALENT TO 300 MG. LITHIUM CARBONATE
CRLK PRIMARY CONTAINER CONTENT QUANTITY 480.000 MILLILITERS OR 500.000 MILLILITERS
CXCY PART NAME ASSIGNED BY CONTROLLING AGENCY LITHIUM CITRATE SYRUP USP 8MEG/5ML 480ML BT
Manufacturing Part Numbers (SKUs)
Part SKU Cage Status RNVC RNCC SADC DAC RNAAC
NDC00054-3527-63 34471 A 2 3 6 54
NDC60432-0616-16 00QD1 A 2 3 4 ZZ
CIBALITH-S SYRUP 04482 A 1 5 4 KX
NDC00083-6565-76 04482 A 9 5 4 KX
NDC00832-8616-16 42623 A 9 5 4 KX
Manufacturers
Part SKU Cage Manufacturer Type Status
NDC00054-3527-63 34471 BOEHRINGER INGELHEIM ROXANE INC. A A
NDC60432-0616-16 00QD1 MORTON GROVE PHARMACEUTICALS INC A A
CIBALITH-S SYRUP 04482 CIBA-GEIGY CORP A A
NDC00083-6565-76 04482 CIBA-GEIGY CORP A A
NDC00832-8616-16 42623 PHARMACEUTICAL BASICS INC A A
FLIS Identification
PMIC ADPE Code CRITL Code DEMIL Code DEMIL INTG NIIN Asgt ESD HMIC ENAC Schedule-B INC
A X A 1 12/10/1 Y 3004909135 3682
FLIS Management
MOE REC Rep Code Mgmt Ctl USC Phrase Code Phrase Statement
DS I
DA C2201X- A
DN 9B----- N
VA V R REFER TO NOT YET AVAIL
VA V K U/I CONTAINS 500 ML
DF ------- F
Demilitarization Codes & Management
DML PMI HMIC ADP CC ESDC
A A Y X
Miscellaneous Management
MOE (S_A) SOS AAC QUP UI SLC CIIC RC MCC SVC
DA SMS L 1 BT Q U C2201X- A
DN SMS L 1 BT Q U 9B----- N
DF SMS L 1 BT Q U ------- F
DS SMS L 1 BT Q U D
VA G36 G 0 BT K U V
Management Control Army
MATCAT 1 MATCAT 2 MATCAT 3 MATCAT 4 5 ARC
C 2 2 01 X
Freight
NMFC NMFC SUB UFC HMC LTL LCL WCC TCC SHC ADC ACC ASH NMF DESC